Novacyl

Form 483 issued July 4, 2014 · Roussillon, France

Inspection
Jun 30 – Jul 4, 2014
Investigator
Linda Thai
Observations
4
Pages
2
FEI number
3009804152

In short: On July 4, 2014, FDA issued a Form 483 with 4 observations to Novacyl in Roussillon, France (FEI 3009804152) after an inspection that ran Jun 30 – Jul 4, 2014. The investigator was Linda Thai. Most observations concern quality system and facilities & equipment.

At a glance

Observations span 2 systems, led by quality system.

Quality system1
Facilities & equipment1
Other2

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    in our firm failed to conduct appropriate investigations to determine the root…

  2. 02

    Your firm failed to conduct an investigation into the excursion of” in the, production of bulk…

  3. 03

    Observation 3: scanned text, readable in the full document.

  4. 04

    Observation 4: scanned text, readable in the full document.

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Novacyl?

FDA listed 4 observations on this Form 483, mostly about quality system and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Novacyl?

Linda Thai is named on this Form 483, for the inspection of Jun 30 – Jul 4, 2014. Each investigator has a profile showing what they cite most.

When was Novacyl inspected by FDA?

The inspection ran Jun 30 – Jul 4, 2014, and the Form 483 is dated July 4, 2014.

How do I get the full Form 483 for Novacyl?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free